BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 23624028)

  • 1. Cancer risk and PCOS.
    Dumesic DA; Lobo RA
    Steroids; 2013 Aug; 78(8):782-5. PubMed ID: 23624028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome and gynecological cancers: is there a link?
    Gadducci A; Gargini A; Palla E; Fanucchi A; Genazzani AR
    Gynecol Endocrinol; 2005 Apr; 20(4):200-8. PubMed ID: 16019362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogen-dependant malignancies?
    Fanta M
    Gynecol Endocrinol; 2013 Feb; 29(2):145-7. PubMed ID: 23127146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?
    Shafiee MN; Khan G; Ariffin R; Abu J; Chapman C; Deen S; Nunns D; Barrett DA; Seedhouse C; Atiomo W
    Gynecol Oncol; 2014 Jan; 132(1):248-53. PubMed ID: 24183733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and risks of ovarian function and reproduction for cancer development and prevention.
    Schindler AE
    Gynecol Endocrinol; 2011 Dec; 27(12):1043-7. PubMed ID: 21501003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
    Bernstein L
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome and endometrial cancer.
    Navaratnarajah R; Pillay OC; Hardiman P
    Semin Reprod Med; 2008 Jan; 26(1):62-71. PubMed ID: 18181084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrium in PCOS: Implantation and predisposition to endocrine CA.
    Giudice LC
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):235-44. PubMed ID: 16772154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polycystic ovary syndrome associated neoplasms].
    Spritzer PM; Morsch DM; Wiltgen D
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):805-10. PubMed ID: 16444364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Does oral contraception cause cancer? (author's transl)].
    Kindermann G
    Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):213-9. PubMed ID: 1261787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and management of abnormal uterine bleeding in premenopausal women.
    Sweet MG; Schmidt-Dalton TA; Weiss PM; Madsen KP
    Am Fam Physician; 2012 Jan; 85(1):35-43. PubMed ID: 22230306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer.
    Papaioannou S; Tzafettas J
    Best Pract Res Clin Obstet Gynaecol; 2010 Feb; 24(1):19-27. PubMed ID: 19264556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial abnormality in women with polycystic ovary syndrome.
    Shang K; Jia X; Qiao J; Kang J; Guan Y
    Reprod Sci; 2012 Jul; 19(7):674-83. PubMed ID: 22534323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Barry JA; Azizia MM; Hardiman PJ
    Hum Reprod Update; 2014; 20(5):748-58. PubMed ID: 24688118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestogen deficiency and endometrial cancer risk.
    Schindler AE
    Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polycystic ovary syndrome and gynecological cancer risk.
    Meczekalski B; Pérez-Roncero GR; López-Baena MT; Chedraui P; Pérez-López FR
    Gynecol Endocrinol; 2020 Apr; 36(4):289-293. PubMed ID: 32103691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.